← Leaderboards
Norma Frizzell
University Of South Carolina At Columbia
$3,422,646
Attributed
$3,689,845
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $666.1K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,689,845 · 7
By mechanism
R01$2,365,465 · 2
R56$639,500 · 2
R21$400,798 · 1
R03$284,082 · 2
Top collaborators
- Rosemarie M Booze2 shared
- Michael Shtutman2 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Michael Shtutman$3,559,355
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsPost-Translational Protein ProcessingLinkMouse ModelPreventFumaratesCitric Acid CycleReactionKnockout MiceAffectMitochondrial DiseasesCysteineNeuronsCellsBiochemicalMitochondriaKnock-OutInflammationGenesLeigh DiseaseBrain StemDefectBioenergeticsBrain
Grant awards (17)
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy$372,500
R01 · FY2025 · NS · contact PI
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy$361,325
R01 · FY2024 · NS · contact PI
Targeting Immunometabolism: a novel role for itaconate in the treatment of HIV-associated neurocognitive disorder and cocaine use disorder$181,708
R21 · FY2024 · DA
Developing Tools to Understand an Alternative Fate of Urate in Neurodegenerative Diseases$74,500
R03 · FY2024 · NS · contact PI
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy$372,500
R01 · FY2023 · NS · contact PI
Targeting Immunometabolism: a novel role for itaconate in the treatment of HIV-associated neurocognitive disorder and cocaine use disorder$219,090
R21 · FY2023 · DA
Developing Tools to Understand an Alternative Fate of Urate in Neurodegenerative Diseases$74,500
R03 · FY2023 · NS · contact PI
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy$372,500
R01 · FY2022 · NS · contact PI
Anaplerotic Therapy for Mitochondrial Complex I Deficiency$372,500
R56 · FY2020 · NS · contact PI
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease$215,669
R01 · FY2018 · NS · contact PI
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease$215,669
R01 · FY2017 · NS · contact PI
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease$215,669
R01 · FY2016 · NS · contact PI
Protein Succination: a Mechanistic Mediator of Adipocyte Dysfunction in Diabetes$133,500
R56 · FY2016 · DK · contact PI
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease$239,633
R01 · FY2015 · NS · contact PI
Protein Succination: a Mechanistic Mediator of Adipocyte Dysfunction in Diabetes$133,500
R56 · FY2015 · DK · contact PI
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease$66,582
R03 · FY2014 · HD · contact PI
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease$68,500
R03 · FY2013 · HD · contact PI